San Francisco, California — The Endocrine Society's Corporate Liaison Board (CLB) will host its annual forum on Sunday June 15, as part of ENDO 08, the Society's 90^th Annual Meeting. The 2008 topic for the forum is "Pathways in the Control of Metabolism: Emerging Links."

The forum includes speakers from industry, academia, and government engaged in multi-perspective discussion on new pathways in the control of metabolism, specifically as they relate to obesity and diabetes. Among the issues to be discussed by forum participants are:

• Pediatric   obesity syndromes
  Jack Yanovski, MD, PhD, National Institutes of Health

• The   implications for obesity drug development through the neuro-hormonal   control of bodyweight
  Christian Weyer, MD, MAS, Amylin Pharmaceuticals

• The   regulation of glucose metabolism
  Gerard Karsenty, MD, PhD, Columbia University Medical Center

The CLB serves as an opportunity for regular and direct communication between the Society, The Hormone Foundation, and the pharmaceutical and biotechnology industry in endocrinology. The 2008 forum will be held at the San Francisco Marriott in the Yerba Buena Ballroom, Salon 8. The session begins at 6:30 p.m. Reporters may register by contacting Charles Blue on (301) 941-0240; cblue@endo-society.org.

# # #

Founded in 1916, The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 14,000 scientists, physicians, educators, nurses and students in more than 80 countries. Together, these members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Md. To learn more about the Society, and the field of endocrinology, visit our web site at www.endo-society.org.